• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.

作者信息

Fedele Pasquale L, Gregory Gareth P, Gilbertson Michael, Shortt Jake, Kumar Beena, Opat Stephen, Grigoriadis George

机构信息

Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.

Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.

出版信息

Ann Hematol. 2016 Mar;95(4):667-8. doi: 10.1007/s00277-016-2601-6. Epub 2016 Jan 23.

DOI:10.1007/s00277-016-2601-6
PMID:26801792
Abstract
摘要

相似文献

1
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.输注剂量调整的疗程联合硼替佐米治疗浆母细胞淋巴瘤。
Ann Hematol. 2016 Mar;95(4):667-8. doi: 10.1007/s00277-016-2601-6. Epub 2016 Jan 23.
2
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.硼替佐米联合EPOCH方案作为浆母细胞淋巴瘤患者的一线治疗有效。
Br J Haematol. 2019 Feb;184(4):679-682. doi: 10.1111/bjh.15156. Epub 2018 Mar 12.
3
[HIV-negative plasmablastic lymphoma attaining sustained remission with bortezomib-combined dose-adjusted EPOCH therapy].[硼替佐米联合剂量调整的EPOCH疗法使HIV阴性浆母细胞淋巴瘤获得持续缓解]
Rinsho Ketsueki. 2017;58(5):443-448. doi: 10.11406/rinketsu.58.443.
4
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis.硼替佐米联合剂量调整的EPOCH（依托泊苷、泼尼松、长春新碱、环磷酰胺和阿霉素）可使浆母细胞淋巴瘤患者长期存活：一项回顾性分析。
Leuk Lymphoma. 2018 Sep;59(9):2121-2127. doi: 10.1080/10428194.2017.1416365. Epub 2018 Jan 5.
5
Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.联合化疗和硼替佐米治疗HIV相关浆母细胞淋巴瘤的持久完全缓解
BMJ Case Rep. 2017 Oct 9;2017:bcr-2017-222063. doi: 10.1136/bcr-2017-222063.
6
Solitary plasmablastic lymphoma in the esophagus.食管孤立性浆母细胞淋巴瘤
Ann Hematol. 2016 Apr;95(5):845-6. doi: 10.1007/s00277-016-2626-x. Epub 2016 Mar 1.
7
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.硼替佐米联合剂量调整的 EPOCH 方案治疗浆母细胞淋巴瘤。
Br J Haematol. 2015 May;169(3):352-5. doi: 10.1111/bjh.13300. Epub 2015 Jan 22.
8
A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.比较挽救性输注化疗方案治疗复发性/难治性多发性骨髓瘤。
Cancer. 2015 Oct 15;121(20):3622-30. doi: 10.1002/cncr.29533. Epub 2015 Jul 6.
9
Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).对剂量调整的R-EPOCH（DA-R-EPOCH）治疗无效的伯基特淋巴瘤。
Ann Hematol. 2014 Jan;93(1):177-8. doi: 10.1007/s00277-013-1771-8. Epub 2013 May 2.
10
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.在预后不良的未经治疗的弥漫性大 B 细胞非霍奇金淋巴瘤的非常老年患者中，使用利妥昔单抗的剂量调整的输注环磷酰胺、多柔比星、长春新碱和泼尼松化疗的活性和安全性。
Cancer. 2011 Mar 1;117(5):964-73. doi: 10.1002/cncr.25582. Epub 2010 Oct 19.

引用本文的文献

1
Meta-analysis of the comparative efficacy and safety of new drugs in combination with chemotherapy in primary plasmoblastic lymphoma.新药联合化疗治疗原发性浆母细胞淋巴瘤的疗效和安全性的Meta分析
Clin Exp Med. 2025 Apr 1;25(1):103. doi: 10.1007/s10238-025-01636-9.
2
Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review.阿来替尼联合VRCD和BV单克隆抗体治疗ALK阳性大B细胞淋巴瘤：1例病例报告及文献复习
Front Oncol. 2025 Jan 21;14:1480880. doi: 10.3389/fonc.2024.1480880. eCollection 2024.
3
Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on Therapy.
浆母细胞淋巴瘤。最新综述：第2部分-聚焦治疗
Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024015. doi: 10.4084/MJHID.2024.015. eCollection 2024.
4
Case Report: Bortezomib Plus CDOP Followed by Sequential Autologous Hematopoietic Stem Cell Transplantation and Lenalidomide-Based Maintenance Therapy in Plasmablastic Lymphoma.病例报告：硼替佐米联合CDOP方案序贯自体造血干细胞移植及来那度胺维持治疗浆母细胞淋巴瘤
Front Med (Lausanne). 2021 Dec 3;8:749863. doi: 10.3389/fmed.2021.749863. eCollection 2021.
5
An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen.一名CD4<20的晚期艾滋病患者合并浆母细胞淋巴瘤采用V-EPOCH方案获得完全缓解。
Cureus. 2020 Jun 15;12(6):e8641. doi: 10.7759/cureus.8641.
6
HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases.HIV阴性浆母细胞淋巴瘤：8例报告及394例已发表病例的综合回顾
Blood Res. 2020 Mar;55(1):49-56. doi: 10.5045/br.2020.55.1.49. Epub 2020 Mar 30.
7
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.沙利度胺-地塞米松诱导及双次自体造血干细胞移植后长期完全缓解的浆母细胞淋巴瘤 1 例报告
BMC Cancer. 2018 Jun 8;18(1):645. doi: 10.1186/s12885-018-4561-9.
8
Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review.浆母细胞淋巴瘤：1例晚期人类免疫缺陷病毒患者长期生存的病例报告及文献综述
Case Rep Hematol. 2017;2017:9561013. doi: 10.1155/2017/9561013. Epub 2017 Sep 24.
9
Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.联合化疗和硼替佐米治疗HIV相关浆母细胞淋巴瘤的持久完全缓解
BMJ Case Rep. 2017 Oct 9;2017:bcr-2017-222063. doi: 10.1136/bcr-2017-222063.
10
Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets.白细胞介素-6 依赖性生长的新建立的浆母细胞淋巴瘤细胞系及其治疗靶点。
Sci Rep. 2017 Aug 31;7(1):10188. doi: 10.1038/s41598-017-10684-5.